Acetazolamide for preventing high altitude illness
Level of Evidence = B
The quality of evidence is downgraded by study limitations (unclear allocation concealment and detection bias).
A Cochrane review 1 included 64 studies with a total of 4547 subjects. The risk of acute mountain sickness (AMS) was reduced with acetazolamide (table T1). Few studies reported side effects for this comparison, and they showed an increase in the risk of paraesthesia with the intake of acetazolamide. For dexamethasone, there was a trend towards reduced acute mountain sickness, but it was insignificant.
Table 1. Acetazolamide/dexamethasone compared with placebo for preventing high altitude illness
|Outcome||Relative effect (95% CI)||Assumed risk - Placebo||Risk with intervention - Acetazolamide||No of Participants (studies)|
|Incidence of acute mountain sickness||RR 0.47 (0.39 to 0.56)||241 per 1000||113 per 1000 (94 to 135)||2301 (16)|
|Incidence of high altitude pulmonary oedema (HAPE)||Not estimable||No events||1138 (7)|
|Incidence of high altitude cerebral oedema (HACE)||RR 0.32 (0.01 to 7.48)||2 per 1000||1 per 1000 (0 to 14)||1126 (6)|
|Outcome||Relative effect (95% CI)||Assumed risk - Placebo||Risk with intervention - Dexamethasone||No of Participants (studies)|
|Incidence of acute mountain sickness||RR 0.6 (0.36 to 1)||449 per 1000||270 per 1000 (162 to 449)||176 (4)|
1. Nieto Estrada VH, Molano Franco D, Medina RD et al. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs. Cochrane Database Syst Rev 2017;(6):CD009761. [PMID:28653390]
Copyright © 2023 Duodecim Medical Publications Limited.
"Acetazolamide for Preventing High Altitude Illness." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305235/all/Acetazolamide_for_preventing_high_altitude_illness.
Acetazolamide for preventing high altitude illness. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305235/all/Acetazolamide_for_preventing_high_altitude_illness. Accessed June 7, 2023.
Acetazolamide for preventing high altitude illness. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305235/all/Acetazolamide_for_preventing_high_altitude_illness
Acetazolamide for Preventing High Altitude Illness [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305235/all/Acetazolamide_for_preventing_high_altitude_illness.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Acetazolamide for preventing high altitude illness ID - 1305235 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305235/all/Acetazolamide_for_preventing_high_altitude_illness PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -